The spectrum of pediatric amplified musculoskeletal pain syndrome.
Activities of Daily Living
Adolescent
Adverse Childhood Experiences
/ psychology
Anxiety
/ epidemiology
Child
Chronic Pain
/ epidemiology
Cohort Studies
Complex Regional Pain Syndromes
/ epidemiology
Cross-Sectional Studies
Depression
/ epidemiology
Female
Fibromyalgia
/ physiopathology
Humans
Male
Musculoskeletal Pain
/ epidemiology
Obsessive-Compulsive Disorder
/ epidemiology
Pain Measurement
Panic Disorder
/ epidemiology
Retrospective Studies
Time Factors
Adolescent
Amplified pain
Child
Fibromyalgia
Intermittent pain
Limited pain
Pain
Widespread pain
Journal
Pediatric rheumatology online journal
ISSN: 1546-0096
Titre abrégé: Pediatr Rheumatol Online J
Pays: England
ID NLM: 101248897
Informations de publication
Date de publication:
12 Oct 2020
12 Oct 2020
Historique:
received:
22
05
2020
accepted:
06
10
2020
entrez:
13
10
2020
pubmed:
14
10
2020
medline:
3
8
2021
Statut:
epublish
Résumé
Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia. We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale. We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001). There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population.
Sections du résumé
BACKGROUND
BACKGROUND
Children presenting with musculoskeletal pain to pediatric rheumatology clinics are very heterogeneous and on a continuum from those with localized pain to total body pain. Many report intermittent, rather than constant, pain. We examined clinical and psychological characteristics of these children at presentation and specifically those who fulfilled the criteria for fibromyalgia.
METHODS
METHODS
We performed a retrospective, cross-sectional cohort study of children under ≤18 years old presenting to the pediatric rheumatology pain clinic between January 2015 and July 2019 and enrolled in a patient registry. We included children diagnosed with amplified pain, excluding those fulfilling criteria for complex regional pain syndrome. Abstracted data included clinical characteristics, pain symptoms, functional disability inventory (FDI), widespread pain index, and symptom severity scale.
RESULTS
RESULTS
We analyzed 636 subjects, predominantly non-Hispanic Caucasian females. Using median split method, 54% had diffuse pain (≥ 5 body regions involved), but, of these, only 58% met criteria for fibromyalgia. Subjects with diffuse pain, compared to those with localized pain had a longer duration of pain (24 vs 12 months, p < 0.01), reported greater pain intensity (6/10 vs 5/10, p < 0.001), greater mental health burden, and poorer function (FDI 25 vs 19, p < 0.0001). Subjects with limited pain more often reported a history of trigger event (34% vs 24%, p < 0.01) but not autonomic changes (14% vs 14%, p = 0.94). The presence of adverse childhood experiences did not differ among those with limited versus diffuse pain except for parental divorce (16% vs 23%, p = 0.03). Intermittent pain was reported in 117 children (18%) and, compared to subjects with constant pain, they reported less pain (0/10 vs 6/10) and were more functional (FDI 13 vs 25) (both p < 0.0001).
CONCLUSIONS
CONCLUSIONS
There exists a wide spectrum of pain manifestations among children with amplified pain including limited or diffuse and constant or intermittent pain. Most children who presented to our clinic did not fulfill criteria for fibromyalgia but nonetheless had significant symptoms and disability. Studies focusing on fibromyalgia may miss the full extent of childhood amplified pain. Additionally, research limited to those meeting the fibromyalgia criteria likely underestimate the significant impact of amplified pain among the pediatric population.
Identifiants
pubmed: 33046102
doi: 10.1186/s12969-020-00473-2
pii: 10.1186/s12969-020-00473-2
pmc: PMC7552512
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
77Références
J Pain. 2016 Dec;17(12):1334-1348
pubmed: 27641311
J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):693-4
pubmed: 18955880
Arthritis Rheum. 2002 Mar;46(3):714-25
pubmed: 11920407
Arch Dis Child. 2020 Oct;105(10):938-944
pubmed: 32152039
J Pediatr. 2015 Sep;167(3):731-7
pubmed: 26209526
J Pediatr. 2016 Feb;169:9-10
pubmed: 26681474
Clin J Pain. 2012 Nov-Dec;28(9):766-74
pubmed: 22688602
JAMA Pediatr. 2014 Dec;168(12):1167-8
pubmed: 25436848
J Pediatr. 2016 Feb;169:181-7.e1
pubmed: 26545727
Pain. 2010 Aug;150(2):268-74
pubmed: 20493633
Arthritis Rheum. 1985 Feb;28(2):138-45
pubmed: 3871615
Psychol Methods. 2002 Mar;7(1):19-40
pubmed: 11928888
J Pediatr Psychol. 1991 Feb;16(1):39-58
pubmed: 1826329
Best Pract Res Clin Rheumatol. 2011 Apr;25(2):133-9
pubmed: 22094190
Acad Pediatr. 2017 Sep - Oct;17(7S):S51-S69
pubmed: 28865661
J Rheumatol. 1992 Nov;19(11):1786-9
pubmed: 1491402
JAMA Pediatr. 2014 Dec;168(12):1167
pubmed: 25436847
JAMA Pediatr. 2014 Aug;168(8):693-4
pubmed: 24887181
Arthritis Care Res (Hoboken). 2010 May;62(5):600-10
pubmed: 20461783
Clin J Pain. 1999 Sep;15(3):218-23
pubmed: 10524475
Arch Dis Child. 1951 Apr;26(126):134-40
pubmed: 14830278
Curr Opin Rheumatol. 2014 Sep;26(5):592-603
pubmed: 25010441
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069